153 related articles for article (PubMed ID: 35135688)
1. Cardioselective Versus Nonselective β-Blockers After Myocardial Infarction in Adults With Chronic Obstructive Pulmonary Disease.
Chung CM; Lin MS; Chang ST; Wang PC; Yang TY; Lin YS
Mayo Clin Proc; 2022 Mar; 97(3):531-546. PubMed ID: 35135688
[TBL] [Abstract][Full Text] [Related]
2. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
3. β-blocker use and mortality in COPD patients after myocardial infarction: a Swedish nationwide observational study.
Andell P; Erlinge D; Smith JG; Sundström J; Lindahl B; James S; Koul S
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25854796
[TBL] [Abstract][Full Text] [Related]
4. Improving outcomes in chronic obstructive pulmonary disease by taking beta-blockers after acute myocardial infarction: a nationwide observational study.
Wang WH; Cheng CC; Mar GY; Wei KC; Huang WC; Liu CP
Heart Vessels; 2019 Jul; 34(7):1158-1167. PubMed ID: 30680495
[TBL] [Abstract][Full Text] [Related]
5. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
[TBL] [Abstract][Full Text] [Related]
6. β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction.
LaFon DC; Helgeson ES; Lindberg S; Voelker H; Bhatt SP; Casaburi R; Cassady SJ; Connett J; Criner GJ; Hatipoglu U; Kaminsky DA; Kunisaki KM; Lazarus SC; McEvoy CE; Reed RM; Sciurba FC; Stringer W; Dransfield MT
JAMA Netw Open; 2024 May; 7(5):e247535. PubMed ID: 38771577
[TBL] [Abstract][Full Text] [Related]
7. Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study.
Dong YH; Chang CH; Wu LC; Lai MS
Eur J Clin Pharmacol; 2016 Oct; 72(10):1265-1273. PubMed ID: 27444174
[TBL] [Abstract][Full Text] [Related]
8. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
[TBL] [Abstract][Full Text] [Related]
9. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
10. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.
Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ
BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921
[TBL] [Abstract][Full Text] [Related]
11. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
[TBL] [Abstract][Full Text] [Related]
12. Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark.
Rasmussen DB; Bodtger U; Lamberts M; Nicolaisen SK; Sessa M; Capuano A; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):23-31. PubMed ID: 30608575
[TBL] [Abstract][Full Text] [Related]
13. β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study.
Su TH; Chang SH; Kuo CF; Liu PH; Chan YL
PLoS One; 2019; 14(3):e0213187. PubMed ID: 30835781
[TBL] [Abstract][Full Text] [Related]
14. [Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease].
Karoli NA; Rebrov AP
Kardiologiia; 2021 Oct; 61(10):89-98. PubMed ID: 34763643
[TBL] [Abstract][Full Text] [Related]
15. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
[TBL] [Abstract][Full Text] [Related]
16. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study.
Short PM; Lipworth SI; Elder DH; Schembri S; Lipworth BJ
BMJ; 2011 May; 342():d2549. PubMed ID: 21558357
[TBL] [Abstract][Full Text] [Related]
17. Selection of β-Blocker in Patients With Cirrhosis and Acute Myocardial Infarction: A 13-Year Nationwide Population-Based Study in Asia.
Wu VC; Chen SW; Ting PC; Chang CH; Wu M; Lin MS; Hsieh MJ; Wang CY; Chang SH; Hung KC; Hsieh IC; Chu PH; Wu CS; Lin YS
J Am Heart Assoc; 2018 Oct; 7(19):e008982. PubMed ID: 30371327
[TBL] [Abstract][Full Text] [Related]
18. Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.
Quint JK; Herrett E; Bhaskaran K; Timmis A; Hemingway H; Wedzicha JA; Smeeth L
BMJ; 2013 Nov; 347():f6650. PubMed ID: 24270505
[TBL] [Abstract][Full Text] [Related]
19. Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.
Salpeter SR; Ormiston TM; Salpeter EE; Poole PJ; Cates CJ
Respir Med; 2003 Oct; 97(10):1094-101. PubMed ID: 14561016
[TBL] [Abstract][Full Text] [Related]
20. Use of cardioselective β-blockers in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized, placebo-controlled, blinded trials.
Ni Y; Shi G; Wan H
J Int Med Res; 2012; 40(6):2051-65. PubMed ID: 23321161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]